Nasacort and Flagyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasacort (triamcinolone acetonide) and Flagyl (metronidazole). Common drug interactions include rib fracture among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Nasacort and Flagyl. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Flagyl?

Flagyl has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 25,897 Flagyl users. Check the latest studies of Flagyl.



On Jul, 15, 2026

70 people who take Nasacort and Flagyl together, and have interactions are studied.

Nasacort and Flagyl drug interactions.

What are the common drug interactions of Nasacort and Flagyl, by gender? *:

female:

  1. Rib fracture
  2. Bone disorder
  3. Intervertebral disc protrusion (spinal disc protrusion)
  4. Neck pain
  5. Pain in jaw
  6. Tendonitis (a condition that causes pain and swelling of tendons)
  7. Exostosis (formation of new bone on the surface of a bone)
  8. Pain in extremity
  9. Synovial cyst (cyst of joint filled with synovial fluid)
  10. Anaemia (lack of blood)

male:

  1. Hypotension (abnormally low blood pressure)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  4. Renal failure (kidney dysfunction)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Respiratory distress (difficulty in breathing)
  7. Abdominal hernia
  8. Acidosis (build-up of carbon dioxide in the blood)
  9. Acute myocardial infarction (acute heart attack)
  10. Acute respiratory failure

What are the common drug interactions of Nasacort and Flagyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug ineffective
  2. Gastrointestinal injury (injury to gastrointestinal tract)
  3. Injury
  4. Pain
  5. Pregnancy with contraceptive device
  6. Procedural pain
  7. Uterine perforation (accidental puncture of the uterus)
  8. Abdominal pain upper
  9. Cardiogenic shock (inadequate circulation of blood)
  10. Cholecystitis chronic (long lasting infection of gallbladder)

20-29:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Abdominal pain
  3. Abdominal pain upper
  4. Hepatic adenoma (benign liver tumour)
  5. Hepatic steatosis (fatty liver disease)
  6. Acute sinusitis
  7. Agitation (state of anxiety or nervous excitement)
  8. Anxiety
  9. Arthropathy
  10. Asthma

30-39:

  1. Abortion spontaneous (naturally occurring miscarriage)
  2. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Abdominal pain upper
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Blood glucose decreased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Chest pain
  7. Chronic obstructive airways disease
  8. Constipation
  9. Cystitis (inflammation of the wall of the bladder)
  10. Decreased activity

50-59:

  1. Pain in jaw
  2. Tenderness (pain or discomfort when an affected area is touched)
  3. Ear pain
  4. Neuropathy peripheral (surface nerve damage)
  5. Rib fracture
  6. Arthralgia (joint pain)
  7. Injury
  8. Nausea (feeling of having an urge to vomit)
  9. Tendonitis (a condition that causes pain and swelling of tendons)
  10. Vomiting

60+:

  1. Arthralgia (joint pain)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Hypophagia (reduced food intake)
  4. Pain
  5. Pain in extremity
  6. Renal cyst (kidney cyst)
  7. Tricuspid valve incompetence (inefficient heart valve)
  8. Vertigo
  9. Abdominal discomfort
  10. Adenoma benign (non-cancerous tumour -secreting)

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 27 people, 38.57%
  2. Breast Cancer: 27 people, 38.57%
  3. Migraine (headache): 22 people, 31.43%
  4. Discomfort: 21 people, 30.00%
  5. Ovarian Cancer (cancer of ovary): 21 people, 30.00%
  6. Hot Flush (sudden feelings of heat): 21 people, 30.00%
  7. Neoplasm Malignant (cancer tumour): 21 people, 30.00%
  8. Granulocyte Count Decreased: 20 people, 28.57%
  9. Restless Leg Syndrome (a powerful urge to move your legs): 13 people, 18.57%
  10. Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 12 people, 17.14%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and Flagyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasacort and Flagyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flagyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasacort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flagyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide and metronidazole (the active ingredients of Nasacort and Flagyl, respectively), and Nasacort and Flagyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: